Kit for NKX2-8 gene hybridization in situ, detection method and application thereof
A detection kit and in situ hybridization technology, applied in the field of kits, can solve the problems of imperfect design ideas of anticancer drugs, unreported detection technology, drug resistance of tumor cells, etc. specific effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] An in situ hybridization detection kit for NKX2-8 gene, comprising hybridization probes, markers and synergists, wherein the sequence of the hybridization probe is completely reverse complementary to the sequence shown in SEQ ID NO.1. Hybridization probes were labeled with digoxigenin. The composition of other liquids and specimens in the kit is as follows:
[0047] Digestive solution 100μl / tube 1 tube / box Colorless transparent liquid
[0048] Protective solution 100μl / tube 1 tube / box Colorless transparent liquid
[0049] Pre-hybridization solution 1300μl / tube 2 tubes / box Colorless transparent liquid
[0050] Sense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid
[0051] Antisense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid
[0052] Blocking solution 1000μl / tube 1 tube / box Colorless transparent liquid
[0053] Alkaline phosphatase antibody 1μl / tube 1 tube / box Colorless transparent liquid
[0054] Chromogen A 17...
Embodiment 2
[0097] A kind of NKX2-8 gene in situ hybridization detection method and its kit application
[0098] 1. Specimen processing
[0099] 1. Use a 10ml centrifuge tube to fill 4.5ml of lymphocyte separation solution, then slowly add 3ml of anticoagulated blood into the centrifuge tube containing lymphocyte separation solution (blood: lymphocyte separation solution = 1:1.5), and centrifuge at 2000r / min 10min;
[0100] 2. Take the white blood cells in the middle layer into another centrifuge tube, then add about twice the amount of 1× buffer I to this tube, mix well, and centrifuge at 1500g / min for 10min;
[0101] 3. Discard the supernatant. Add about twice the 1× buffer I to the precipitate, mix well, and centrifuge at 1500g / min for 10min;
[0102] 4. Discard the supernatant, and absorb the excess liquid from the mouth of the test tube with paper towels. Then the precipitate was made into a suspension, dropped on a glass slide, and allowed to dry naturally. (Hospitals with condi...
Embodiment 3
[0137] A comparative experiment between the detection of lung cancer disease with the NKX2-8 gene kit and the detection of lung cancer disease with the TIG2 gene kit.
[0138] In order to scientifically evaluate the specificity, sensitivity and accuracy of the above genes in lung cancer. We use the parallel test method to detect the mRNA of the above genes at the same time. The detection technology adopts nucleic acid in situ hybridization technology, and uses the peripheral blood of the same patient with lung cancer to simultaneously detect the mRNA of NKX2-8 gene and TIG2 gene (nucleic acid in situ hybridization , immunohistochemical staining, microscopic counting, result reporting, etc. all adopt the same method and steps and reagents as the in situ hybridization technique of Example 1 and Example 2). It is found that the expression level of NKX2-8 gene in patients with lung cancer is higher than that of TIG2 gene in patients with the same disease. The results showed that ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com